Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

ClinicalTrials.gov ID: NCT01714726

Public ClinicalTrials.gov record NCT01714726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 12:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to evaluate the clinical efficacy and safety of MEDI2070 as compared to placebo. Investigational product will be administered as intravenous infusion in double-blind period, and as a subcutaneous injection in open-label period

Study identification

NCT ID
NCT01714726
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2013 (Actual)
Primary completion
May 20, 2014 (Actual)
Completion
Dec 14, 2016 (Actual)
Last update posted
May 26, 2021

2013 – 2016

United States locations

U.S. sites
26
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Research Site Encinitas California 92024 —
Research Site Los Angeles California 45242 —
Research Site San Diego California 92114 —
Research Site Torrance California 90505 —
Research Site Lakewood Colorado 80215 —
Research Site Jacksonville Florida 32256 —
Research Site Miami Florida 33136 —
Research Site Winter Park Florida 32789 —
Research Site Macon Georgia 31201 —
Research Site Chicago Illinois 60637 —
Research Site Baton Rouge Louisiana 70809 —
Research Site Hammond Louisiana 70403 —
Research Site Baltimore Maryland 21201 —
Research Site Chevy Chase Maryland 20815 —
Research Site Ann Arbor Michigan 48109 —
Research Site Troy Michigan 48098 —
Research Site Belton Missouri 64012 —
Research Site New York New York 10021 —
Research Site New York New York 10029 —
Research Site Asheville North Carolina 28801 —
Research Site Charlotte North Carolina 28207 —
Research Site Cincinnati Ohio 45219 —
Research Site Lima Ohio 45806 —
Research Site Germantown Tennessee 38138 —
Research Site San Antonio Texas 78229 —
Research Site Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01714726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2021 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01714726 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →